Abstract

Tuberculous meningitis (TBM) is the most dangerous form of tuberculosis with high mortality and disability rates. However, the delayed diagnostic process is often due to the absence of the gold standard tests leading to a lack of information about the sensitivity and specificity of diagnostic tests. This study aims to estimate the prevalence of TBM and determine the performance of four diagnostic procedures: the mycobacteria growth culture test, Gene Xpert assay, and analysis of protein levels and leukocyte count taken from cerebrospinal fluid. We used a Bayesian latent class analysis to estimate the prevalence of TBM with 95% credible interval (CI), and the specificity and sensitivity of the four diagnostic procedures. The area under the receiver operating characteristic curve (AUC) of the cerebrospinal protein levels and leukocyte count were also compared and estimated using different thresholds. A total of 1,213 patients suspected of having TBM were included. The estimated TBM prevalence was 34.8 % (95% CI: 28.8 - 41.3). The sensitivity of culture test and Gene Xpert assay was 62.7% (95% CI: 52.5 - 74.0), and 57.5% (95% CI: 51.0 - 64.0), and the specificity of Gene-Xpert was 95. 9% (95% CI: 92.0 - 99.8). The AUC for leukocyte count was 76.0%, and for protein level was 73.4%. This study provided better information about the performance of four routine diagnostic tests and the prevalence of TBM which can enhance disease control and improve treatment outcomes.

Highlights

  • Tuberculous meningitis (TBM) is the most dangerous form of tuberculosis with high mortality and disability rates

  • According to the Tuberculosis Global Report 2017 published by the World Health Organization (WHO), it is one of the ten leading causes of death worldwide

  • All patients suspected of having tuberculosis meningitis (TBM) who had cerebrospinal fluid collected by lumbar puncture immediately after hospital admission and before anti-biotic usage were included

Read more

Summary

Introduction

Tuberculous meningitis (TBM) is the most dangerous form of tuberculosis with high mortality and disability rates. This study aims to estimate the prevalence of TBM and determine the performance of four diagnostic procedures: the mycobacteria growth culture test, Gene Xpert assay, and analysis of protein levels and leukocyte count taken from cerebrospinal fluid. The mortality rate of TBM was reported to be nearly 20% in the first month of treatment and left 50% of patients living with severe neurological sequelae [3]. As it is a heterogeneous neurological disease with complicated and non-specific symptoms, there is no single test or symptom to confirm TBM. The diagnostic process is often delayed due to a lack of information about the accuracy of diagnostic tests and clinical symptoms

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call